Skip to main content
HR 3719 114th Congress House Crime and Law Enforcement Civil actions and liability Congressional oversight Correctional facilities and imprisonment Criminal investigation, prosecution, interrogation Criminal justice information and records Criminal procedure and sentencing Drug trafficking and controlled substances Drug, alcohol, tobacco use Emergency medical services and trauma care Executive agency funding and structure Federal preemption Government studies and investigations Health information and medical records Health personnel Health programs administration and funding Health technology, devices, supplies Law enforcement administration and funding Law enforcement officers Licensing and registrations

STOP ABUSE Act of 2015

Introduced: October 8, 2015 See on congress.gov
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 3, 2015
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Oct 20, 2015
Sponsor introductory remarks on measure. (CR H7013)
Oct 9, 2015
Referred to the Subcommittee on Health.
Oct 8, 2015
Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 8, 2015
Introduced in House
 Plain-English summary Congressional Research Service

Stop the Overdose Problem Already Becoming a Universal Substance Epidemic Act of 2015 or the STOP ABUSE Act of 2015

This bill requires the Department of Health and Human Services to convene an interagency task force to develop, solicit input on, disseminate information about, and study implementation of best practices for pain management and prescription of pain medication.

It amends the Omnibus Crime Control and Safe Streets Act of 1968 to authorize the Department of Justice to award grants:

  • to implement comprehensive community-wide prevention strategies to address a rapid increase or high rate of opioid or prescription drug abuse; and
  • to develop, implement, or expand treatment alternative to incarceration programs.

This bill limits an individual's civil liability for harm caused by the emergency administration of an opioid overdose reversal drug (e.g., naloxone) if the individual:

  • works or volunteers at an opioid overdose program and provides the drug, as a part the program, to an authorized individual who administers it; or
  • administers the drug after obtaining it from a health care professional or as part of an opioid overdose program, or administers it pursuant to a prescription, and was educated on its administration.

It amends the Controlled Substances Act to require an opioid treatment program that closes on any day to make arrangements for each patient to receive treatment during the closure, as necessary.

The bill reauthorizes the High Intensity Drug Trafficking Areas program through FY2020.

It amends the National All Schedules Prescription Electronic Reporting Act of 2005 to include as a specified purpose of state-administered controlled substance monitoring systems ensuring that appropriate authorities have access to prescription history information for investigations.

The bill amends the Public Health Service Act to revise and reauthorize through FY2020 the controlled substance monitoring program.

What's happening now November 3, 2015

Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

 Committees of jurisdiction 4